Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
13F holders, Q3 2023
Institutional positions in Aclarion, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −4 vs. Q2 2023
- Shares held
- 538.4K
- −77.3K (−12.6%) vs. Q2 2023
- Total value
- $175.9K
- −$247.7K (−58.5%) vs. Q2 2023
- New holders
- 2
- 2 more added
- Sold out
- 6
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $332.1K |
| Q1 2026 | 10 | $368.1K |
| Q4 2025 | 8 | $80.2K |
| Q3 2025 | 8 | $168.0K |
| Q2 2025 | 5 | $13.7K |
| Q1 2025 | 6 | $734 |
| Q4 2024 | 9 | $66.4K |
| Q3 2024 | 9 | $68.4K |
| Q2 2024 | 9 | $94.2K |
| Q1 2024 | 7 | $89.4K |
| Q4 2023 | 9 | $124.0K |
| Q3 2023 | 9 | $175.9K |
| Q2 2023 | 13 | $423.6K |
| Q1 2023 | 8 | $114.0K |
| Q4 2022 | 5 | $19.2K |
| Q3 2022 | 9 | $123.0K |
| Q2 2022 | 3 | $66.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aclarion, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 427,646 | $139.2K | 0.00% | +75,676+21.5% | Added |
| Geode Capital Management, LLC | 31,316 | $10.6K | 0.00% | +31,316 | New |
| Renaissance Technologies LLC | 28,100 | $9.00K | 0.00% | −4,232−13.1% | Reduced |
| Citadel Advisors LLC | 17,210 | $5.83K | 0.00% | −12,960−43.0% | Reduced |
| State Street Corp | 15,801 | $5.36K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,324 | $4.34K | 0.00% | −30.0% | Reduced |
| Whittier Trust Co | 4,820 | $1.54K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 134 | $44 | 0.00% | +134 | New |
| Wells Fargo & Company | 39 | $13 | 0.00% | +23+143.8% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −50,081−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,517−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −35,143−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −20,430−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,122−100.0% | Sold out |
| V Wealth Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |